References
- HallPSHamiltonPHulmeCTCosts of cancer care for use in economic evaluation: a UK analysis of patient-level routine health system dataBr J Cancer2015112594895625602964
- LomasALeonardi-BeeJBath-HextallFA systematic review of worldwide incidence of nonmelanoma skin cancerBr J Dermatol201216651069108022251204
- MistryMParkinDMAhmadASSasieniPCancer incidence in the United Kingdom: projections to the year 2030Br J Cancer2011105111795180322033277
- MyersERMoormanPGierischJMBenefits and harms of breast cancer screening: a systematic reviewJAMA2015314151615163426501537
- RaoRWiechmannLTreatment of early breast cancerMinerva Endocrinol200934431132420046160
- MarmotMGAltmanDGCameronDADewarJAThompsonSGWilcoxMThe benefits and harms of breast cancer screening: an independent reviewBr J Cancer2013108112205224023744281
- Independent-UK-Panel-on-Breast-Cancer-ScreeningThe benefits and harms of breast cancer screening: an independent reviewLancet201238098551778178623117178
- Downs-HolmesCSilvermanPBreast cancer: overview & updatesNurse Pract201136122026 quiz 722089837
- Cancer-ResearchBreast cancer mortality statisticsCancer ResearchUK2015 Available from: http://www.cancerresearchuk.org/health-professional/cancer-statistics/statistics-by-cancer-type/breast-cancer/mortality-ref-0Accessed February 26, 2016
- LawlessGDThe working patient with cancer: implications for payers and employersAm Health Drug Benefits20092416817325126288
- NguyenJCramarossaGBrunerDA literature review of symptom clusters in patients with breast cancerExpert Rev Pharmacoecon Outcomes Res201111553353921958098
- RafteryJChorozoglouMPossible net harms of breast cancer screening: updated modelling of Forest reportBMJ2011343d762722155336
- Cancer-ResearchBreast screening statisticscancer researchUK2015 Available from: http://www.cancerresearchuk.org/health-professional/cancer-statistics/statistics-by-cancer-type/breast-cancer/screeningAccessed February 26, 2016
- LobergMLousdalMLBretthauerMKalagerMBenefits and harms of mammography screeningBreast Cancer Res2015176325928287
- GotzschePCJorgensenKJScreening for breast cancer with mammographyCochrane Database Syst Rev20136CD001877
- Taylor-PhillipsSO’SullivanEKearinsOParsonsHClarkeAThe effects of a UK review of breast cancer screening on uptake: an observational before/after studyJ Med Screen2013202869024009089
- MorrisSDevlinNParkinDEconomic Analysis in Health CareChichester, UKJohn Wiley & Sons2007
- HaywoodKLGarrattAMLallRSmithJFLambSEEuroQol EQ-5D and condition-specific measures of health outcome in women with urinary incontinence: reliability, validity and responsivenessQuality Life Res2008173475483
- NICEGuide to the methods of technology appraisalNational Institute for Health and Care Excellence2013
- WhiteheadSJAliSHealth outcomes in economic evaluation: the QALY and utilitiesBr Med Bull20109652121037243
- AndersonPPhillipsCWhat is a QALY? Available from: http://www.whatisseries.co.uk/what-is-a-qaly/Accessed March 3, 20172222017
- MillerABScreening for breast cancer – is there an alternative to mammography?Asian Pac J Cancer Prev200561838615780039
- YaffeMJMainprizeJGRisk of radiation-induced breast cancer from mammographic screeningRadiology201125819810521081671
- NIHbreast cancer screening–for health professionals (PDQ®)National cancer Institute2016 Available from: http://www.cancer.gov/types/breast/hp/breast-screening-pdqAccessed February 26, 2016
- PharoahPDSewellBFitzsimmonsDBennettHSPashayanNCost effectiveness of the NHS breast screening programme: life table modelBMJ2013346f261823661112
- CSIDiscount rates and net present value: Centre for Social Impact2016 Available from: https://data.gov.uk/sib_knowledge_box/discount-rates-and-net-present-valueAccessed February 26, 2016
- HarkerRNHS funding and expenditureStandard Note: SN/SG/724Library; House of Commons2012
- MadanJRawdinAStevensonMTappendenPA rapid-response economic evaluation of the UK NHS cancer reform strategy breast cancer screening program extension via a plausible bounds approachValue Health201013221522119878494
- RobertsonCArcot RagupathySKBoachieCThe clinical effectiveness and cost-effectiveness of different surveillance mammography regimens after the treatment for primary breast cancer: systematic reviews registry database analyses and economic evaluationHealth Technol Assess20111534vvi1322
- GrootMTBaltussenRUyl-de GrootCAAndersonBOHortobagyiGNCosts and health effects of breast cancer interventions in epidemiologically different regions of Africa, North America, and AsiaBreast J200612Suppl 1S819016430401
- ChaloupkaFJWarnerKEAcemogluDAn evaluation of the FDA’s analysis of the costs and benefits of the graphic warning label regulationTob Control201524211211925550419
- HendersonJBAn economic appraisal of the benefits of screening for open spina bifidaSoc Sci Med19821655455606808668
- WolkRBHidden costs of mobile mammography: is subsidization necessary?AJR Am J Roentgenol19921586124312451590115
- DevlinNParkinDDoes NICE have a cost-effectiveness threshold and what other factors influence its decisions? A binary choice analysisHealth Econ200413543745215127424